167 related articles for article (PubMed ID: 33689732)
1. Effect of a smartphone-based intervention on secondary prevention medication prescriptions after coronary artery bypass graft surgery: The MISSION-1 randomized controlled trial.
Qu J; Du J; Rao C; Chen S; Gu D; Li J; Zhang H; Zhao Y; Hu S; Zheng Z;
Am Heart J; 2021 Jul; 237():79-89. PubMed ID: 33689732
[TBL] [Abstract][Full Text] [Related]
2. Rationale and design of a randomized cluster trial to improve guideline-adherence of secondary preventive drugs prescription after coronary artery bypass grafting in China: Measurement and Improvement Studies of Surgical Coronary Revascularization: Secondary Prevention (MISSION-1) Study.
Rao C; Du J; Li X; Li J; Zhang H; Zhao Y; Hu S; Jiang L; Zheng Z;
Am Heart J; 2016 Aug; 178():9-18. PubMed ID: 27502847
[TBL] [Abstract][Full Text] [Related]
3. Association of a P2Y12 Inhibitor Copayment Reduction Intervention With Persistence and Adherence With Other Secondary Prevention Medications: A Post Hoc Analysis of the ARTEMIS Cluster-Randomized Clinical Trial.
Fanaroff AC; Peterson ED; Kaltenbach LA; Cannon CP; Choudhry NK; Henry TD; Anstrom KJ; Cohen DJ; Fonseca E; Khan ND; Fonarow GC; Wang TY
JAMA Cardiol; 2020 Jan; 5(1):38-46. PubMed ID: 31721978
[TBL] [Abstract][Full Text] [Related]
4. The impact of pharmacist-initiated interventions in improving acute coronary syndrome secondary prevention pharmacotherapy prescribing upon discharge.
Hassan Y; Kassab Y; Abd Aziz N; Akram H; Ismail O
J Clin Pharm Ther; 2013 Apr; 38(2):97-100. PubMed ID: 23441979
[TBL] [Abstract][Full Text] [Related]
5. Secondary prevention following coronary artery bypass grafting has improved but remains sub-optimal: the need for targeted follow-up.
Turley AJ; Roberts AP; Morley R; Thornley AR; Owens WA; de Belder MA
Interact Cardiovasc Thorac Surg; 2008 Apr; 7(2):231-4. PubMed ID: 18234766
[TBL] [Abstract][Full Text] [Related]
6. Do practice gaps exist in evidence-based medication prescription at hospital discharge in patients undergoing coronary artery bypass surgery & coronary angioplasty?
Pereira P; Kapoor A; Sinha A; Agarwal SK; Pande S; Khanna R; Srivastava N; Kumar S; Garg N; Tewari S; Goel P
Indian J Med Res; 2017 Dec; 146(6):722-729. PubMed ID: 29664030
[TBL] [Abstract][Full Text] [Related]
7. Smartphone-based application to improve medication adherence in patients after surgical coronary revascularization.
Yu C; Liu C; Du J; Liu H; Zhang H; Zhao Y; Yang L; Li X; Li J; Wang J; Wang H; Liu Z; Rao C; Zheng Z;
Am Heart J; 2020 Oct; 228():17-26. PubMed ID: 32745732
[TBL] [Abstract][Full Text] [Related]
8. Utilization of secondary prevention therapies in patients with nonobstructive coronary artery disease identified during cardiac catheterization: insights from the National Cardiovascular Data Registry Cath-PCI Registry.
Maddox TM; Ho PM; Roe M; Dai D; Tsai TT; Rumsfeld JS
Circ Cardiovasc Qual Outcomes; 2010 Nov; 3(6):632-41. PubMed ID: 20923997
[TBL] [Abstract][Full Text] [Related]
9. Use of medications for secondary prevention after coronary bypass surgery compared with percutaneous coronary intervention.
Hlatky MA; Solomon MD; Shilane D; Leong TK; Brindis R; Go AS
J Am Coll Cardiol; 2013 Jan; 61(3):295-301. PubMed ID: 23246391
[TBL] [Abstract][Full Text] [Related]
10. Prescription Rates of Guideline-Directed Medications Are Associated With In-Hospital Mortality Among Japanese Patients With Acute Myocardial Infarction: A Report From JROAD - DPC Study.
Nakao K; Yasuda S; Nishimura K; Noguchi T; Nakai M; Miyamoto Y; Sumita Y; Shishido T; Anzai T; Ito H; Tsutsui H; Saito Y; Komuro I; Ogawa H
J Am Heart Assoc; 2019 Apr; 8(7):e009692. PubMed ID: 30909774
[TBL] [Abstract][Full Text] [Related]
11. [Impact of different intervention models on adherence to secondary prevention therapies in patients with acute coronary syndrome].
Liu J; Wang W; Liu J; Wang Y; Qi Y; Sun JY; Zhao D
Zhonghua Xin Xue Guan Bing Za Zhi; 2018 Feb; 46(2):124-130. PubMed ID: 29495236
[No Abstract] [Full Text] [Related]
12. Adherence to statins, beta-blockers and angiotensin-converting enzyme inhibitors following a first cardiovascular event: a retrospective cohort study.
Blackburn DF; Dobson RT; Blackburn JL; Wilson TW; Stang MR; Semchuk WM
Can J Cardiol; 2005 May; 21(6):485-8. PubMed ID: 15917876
[TBL] [Abstract][Full Text] [Related]
13. Prescribing Performance Post-Acute Coronary Syndrome Using a Composite Medication Indicator: ANZACS-QI 24.
Kasargod C; Devlin G; Lee M; White HD; Kerr AJ
Heart Lung Circ; 2020 Jun; 29(6):824-834. PubMed ID: 31255479
[TBL] [Abstract][Full Text] [Related]
14. A comparison between statin with ACE inhibitor or ARB therapy in STEMI patients who underwent successful PCI with drug-eluting stents.
Kim YH; Her AY; Jeong MH; Kim BK; Hong SJ; Kim S; Ahn CM; Kim JS; Ko YG; Choi D; Hong MK; Jang Y
Atherosclerosis; 2019 Oct; 289():109-117. PubMed ID: 31491742
[TBL] [Abstract][Full Text] [Related]
15. Recent Trends in Adherence to Secondary Prevention Guidelines for Patients Undergoing Coronary Revascularization in Washington State: An Analysis of the Clinical Outcomes Assessment Program (COAP) Registry.
Riley RF; Don CW; Aldea GS; Mokadam NA; Probstfield J; Maynard C; Goss JR
J Am Heart Assoc; 2012 Aug; 1(5):e002733. PubMed ID: 26600570
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of preventive cardiovascular pharmacotherapy after coronary artery bypass graft surgery.
Barry AR; Koshman SL; Norris CM; Ross DB; Pearson GJ
Pharmacotherapy; 2014 May; 34(5):464-72. PubMed ID: 24877186
[TBL] [Abstract][Full Text] [Related]
17. Reasons for discontinuation of recommended therapies according to the patients after acute coronary syndromes.
Gencer B; Rodondi N; Auer R; Räber L; Klingenberg R; Nanchen D; Carballo D; Vogt P; Carballo S; Meyer P; Matter CM; Windecker S; Lüscher TF; Mach F
Eur J Intern Med; 2015 Jan; 26(1):56-62. PubMed ID: 25582072
[TBL] [Abstract][Full Text] [Related]
18. Guideline-Based Medications for Older Adults Discharged after Percutaneous Coronary Intervention in a Suburban City of Japan: A Cohort Study Using Claims Data.
Shimada K; Hamada S; Sawano M; Yamamoto H; Yoshie S; Iijima K; Miyata H
Tohoku J Exp Med; 2020 Oct; 252(2):143-152. PubMed ID: 33028759
[TBL] [Abstract][Full Text] [Related]
19. The impact of age and chronic kidney disease on secondary prevention post-primary percutaneous coronary intervention.
Zachariah D; Brown R; Kanagala P; Bashir A; Mohan M; Callan P; Rajendra R; Clark AL; Squire I; Gunning M; Lang CC; Kalra PR
QJM; 2014 Mar; 107(3):185-92. PubMed ID: 24194563
[TBL] [Abstract][Full Text] [Related]
20. Comparative Effectiveness of Combination Therapy with Statins and Angiotensin-Converting Enzyme Inhibitors versus Angiotensin II Receptor Blockers in Patients with Coronary Heart Disease: A Nationwide Population-Based Cohort Study in Korea.
Lee J; Lee S
Pharmacotherapy; 2018 Nov; 38(11):1095-1105. PubMed ID: 30225928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
